Researchers report the first vaccine shown to protect nonhuman primates from melioidosis, a disease caused by Burkholderia pseudomallei. The findings appeared in a scientific journal and are described as a key step toward human clinical trials.
The bacteria live in soil and groundwater and can cause aggressive pneumonia or sepsis. The disease is thought to be underreported worldwide; estimates put the annual case count in the hundreds of thousands. Mortality is high partly because the bacteria resist many antibiotics and relapse can occur after treatment.
The vaccine uses outer membrane vesicles, nanoparticles from bacteria that trigger immune responses. Tests on human immune cell samples produced antibody and T cell responses, which suggest the vaccine could work in people. Development took more than a decade and involved international collaboration, and researchers say they aim to start human trials.
Difficult words
- melioidosis — Serious infectious disease caused by soil bacteria
- primate — Mammal like monkeys or apesnonhuman primates
- sepsis — Dangerous body-wide reaction to infection
- mortality — Number of deaths in a group
- antibiotic — Medicine that kills or stops bacteriaantibiotics
- vesicle — Small particle released from a bacterial cellouter membrane vesicles
- relapse — Return of a disease after treatment ends
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why are human clinical trials the next important step after tests on nonhuman primates?
- How might antibiotic resistance affect treatment and prevention of this disease in your country?
- If a vaccine becomes available, what challenges could public health teams face to deliver it in areas with the bacteria?
Related articles
New ultrasound method improves diagnosis of breast masses
Researchers developed a new ultrasound signal-processing method that distinguishes fluid cysts from solid breast masses. In initial patient tests doctors identified masses correctly far more often than with conventional ultrasound, which could reduce biopsies and follow-ups.
AI to stop tobacco targeting young people
At a World Conference in Dublin (23–25 June), experts said artificial intelligence can help stop tobacco companies targeting young people online. They warned social media and new nicotine products draw youth into addiction, and poorer countries carry the heaviest burden.
India's rice export ban prompts push for hybrid rice
India's ban on exports of non-basmati white rice aims to protect local supplies but has tightened global food stocks. Experts and some countries are turning to hybrid rice and investment in farming, while programmes in Asia and Africa expand.
Brain differences in WTC responders with PTSD
New imaging research of World Trade Center responders finds measurable brain structure differences linked to long-term PTSD. Researchers used gray-white contrast (GWC) MRI and other markers to distinguish responders with and without PTSD.